Logo image of ZIL2.DE

ELRINGKLINGER AG (ZIL2.DE) Stock Fundamental Analysis

FRA:ZIL2 - Deutsche Boerse Ag - DE0007856023 - Common Stock - Currency: EUR

4.985  +0.17 (+3.42%)

Fundamental Rating

3

ZIL2 gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 30 industry peers in the Automobile Components industry. ZIL2 may be in some trouble as it scores bad on both profitability and health. ZIL2 has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

ZIL2 had negative earnings in the past year.
In the past year ZIL2 had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: ZIL2 reported negative net income in multiple years.
Each year in the past 5 years ZIL2 had a positive operating cash flow.
ZIL2.DE Yearly Net Income VS EBIT VS OCF VS FCFZIL2.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

1.2 Ratios

ZIL2 has a Return On Assets of -7.84%. This is amonst the worse of the industry: ZIL2 underperforms 83.33% of its industry peers.
With a Return On Equity value of -21.65%, ZIL2 is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -7.84%
ROE -21.65%
ROIC N/A
ROA(3y)-3.41%
ROA(5y)-1.93%
ROE(3y)-9.27%
ROE(5y)-5.38%
ROIC(3y)N/A
ROIC(5y)N/A
ZIL2.DE Yearly ROA, ROE, ROICZIL2.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

In the last couple of years the Operating Margin of ZIL2 has declined.
Looking at the Gross Margin, with a value of 22.14%, ZIL2 is doing worse than 63.33% of the companies in the same industry.
In the last couple of years the Gross Margin of ZIL2 has grown nicely.
ZIL2 does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.14%
OM growth 3Y-19.39%
OM growth 5Y-2.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.81%
GM growth 5Y3.28%
ZIL2.DE Yearly Profit, Operating, Gross MarginsZIL2.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

3

2. Health

2.1 Basic Checks

ZIL2 does not have a ROIC to compare to the WACC, probably because it is not profitable.
ZIL2 has about the same amout of shares outstanding than it did 1 year ago.
Compared to 5 years ago, ZIL2 has about the same amount of shares outstanding.
Compared to 1 year ago, ZIL2 has an improved debt to assets ratio.
ZIL2.DE Yearly Shares OutstandingZIL2.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
ZIL2.DE Yearly Total Debt VS Total AssetsZIL2.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

Based on the Altman-Z score of 1.48, we must say that ZIL2 is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of ZIL2 (1.48) is worse than 63.33% of its industry peers.
The Debt to FCF ratio of ZIL2 is 9.58, which is on the high side as it means it would take ZIL2, 9.58 years of fcf income to pay off all of its debts.
ZIL2 has a Debt to FCF ratio (9.58) which is comparable to the rest of the industry.
ZIL2 has a Debt/Equity ratio of 0.53. This is a neutral value indicating ZIL2 is somewhat dependend on debt financing.
ZIL2's Debt to Equity ratio of 0.53 is fine compared to the rest of the industry. ZIL2 outperforms 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 9.58
Altman-Z 1.48
ROIC/WACCN/A
WACC5.41%
ZIL2.DE Yearly LT Debt VS Equity VS FCFZIL2.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

2.3 Liquidity

A Current Ratio of 1.39 indicates that ZIL2 should not have too much problems paying its short term obligations.
With a Current ratio value of 1.39, ZIL2 perfoms like the industry average, outperforming 56.67% of the companies in the same industry.
ZIL2 has a Quick Ratio of 1.39. This is a bad value and indicates that ZIL2 is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of ZIL2 (0.67) is worse than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.39
Quick Ratio 0.67
ZIL2.DE Yearly Current Assets VS Current LiabilitesZIL2.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for ZIL2 have decreased strongly by -450.62% in the last year.
The Revenue has decreased by -2.38% in the past year.
The Revenue has been growing slightly by 0.87% on average over the past years.
EPS 1Y (TTM)-450.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-565.56%
Revenue 1Y (TTM)-2.38%
Revenue growth 3Y3.54%
Revenue growth 5Y0.87%
Sales Q2Q%2.97%

3.2 Future

Based on estimates for the next years, ZIL2 will show a very strong growth in Earnings Per Share. The EPS will grow by 70.88% on average per year.
ZIL2 is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.67% yearly.
EPS Next Y315.67%
EPS Next 2Y118.71%
EPS Next 3Y70.88%
EPS Next 5YN/A
Revenue Next Year-5.73%
Revenue Next 2Y-1.26%
Revenue Next 3Y-0.48%
Revenue Next 5Y1.67%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ZIL2.DE Yearly Revenue VS EstimatesZIL2.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
ZIL2.DE Yearly EPS VS EstimatesZIL2.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1 1.5

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

ZIL2 reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 7.31, which indicates a rather cheap valuation of ZIL2.
Based on the Price/Forward Earnings ratio, ZIL2 is valued a bit cheaper than 66.67% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.44. ZIL2 is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 7.31
ZIL2.DE Price Earnings VS Forward Price EarningsZIL2.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ZIL2 is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ZIL2 is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 8.28
EV/EBITDA 3.63
ZIL2.DE Per share dataZIL2.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
ZIL2's earnings are expected to grow with 70.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y118.71%
EPS Next 3Y70.88%

More info and screens

3

5. Dividend

5.1 Amount

ZIL2 has a Yearly Dividend Yield of 3.11%.
Compared to an average industry Dividend Yield of 5.47, ZIL2 has a dividend in line with its industry peers.
ZIL2's Dividend Yield is a higher than the S&P500 average which is at 2.44.
Industry RankSector Rank
Dividend Yield 3.11%

5.2 History

The dividend of ZIL2 decreases each year by -23.34%.
Dividend Growth(5Y)-23.34%
Div Incr Years0
Div Non Decr Years2
ZIL2.DE Yearly Dividends per shareZIL2.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.05 0.1

5.3 Sustainability

DP0%
EPS Next 2Y118.71%
EPS Next 3Y70.88%
ZIL2.DE Yearly Income VS Free CF VS DividendZIL2.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M

More info and screens

ELRINGKLINGER AG

FRA:ZIL2 (5/9/2025, 7:00:00 PM)

4.985

+0.17 (+3.42%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)05-08 2025-05-08
Earnings (Next)08-06 2025-08-06
Inst Owners3.9%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap315.85M
Analysts73.85
Price Target5.1 (2.31%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.11%
Yearly Dividend0.15
Dividend Growth(5Y)-23.34%
DP0%
Div Incr Years0
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-5.88%
PT rev (3m)-6.98%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-3.9%
EPS NY rev (3m)-0.95%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-3.68%
Revenue NY rev (3m)-4.11%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.31
P/S 0.18
P/FCF 8.28
P/OCF 1.88
P/B 0.5
P/tB 0.61
EV/EBITDA 3.63
EPS(TTM)-2.18
EYN/A
EPS(NY)0.68
Fwd EY13.68%
FCF(TTM)0.6
FCFY12.07%
OCF(TTM)2.65
OCFY53.2%
SpS28.46
BVpS10.05
TBVpS8.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.84%
ROE -21.65%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.14%
FCFM 2.11%
ROA(3y)-3.41%
ROA(5y)-1.93%
ROE(3y)-9.27%
ROE(5y)-5.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)5.36%
ROCE(5y)5%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-19.39%
OM growth 5Y-2.04%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.81%
GM growth 5Y3.28%
F-Score4
Asset Turnover1.02
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 9.58
Debt/EBITDA 2.26
Cap/Depr 43.38%
Cap/Sales 7.2%
Interest Coverage N/A
Cash Conversion 112.5%
Profit Quality N/A
Current Ratio 1.39
Quick Ratio 0.67
Altman-Z 1.48
F-Score4
WACC5.41%
ROIC/WACCN/A
Cap/Depr(3y)55.78%
Cap/Depr(5y)58.16%
Cap/Sales(3y)5.89%
Cap/Sales(5y)5.57%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-450.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-565.56%
EPS Next Y315.67%
EPS Next 2Y118.71%
EPS Next 3Y70.88%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.38%
Revenue growth 3Y3.54%
Revenue growth 5Y0.87%
Sales Q2Q%2.97%
Revenue Next Year-5.73%
Revenue Next 2Y-1.26%
Revenue Next 3Y-0.48%
Revenue Next 5Y1.67%
EBIT growth 1Y-280.98%
EBIT growth 3Y-16.53%
EBIT growth 5Y-1.19%
EBIT Next Year2542.64%
EBIT Next 3Y212.02%
EBIT Next 5YN/A
FCF growth 1Y24.06%
FCF growth 3Y-17.62%
FCF growth 5Y-25.51%
OCF growth 1Y29.55%
OCF growth 3Y2.48%
OCF growth 5Y-9.55%